![Robert Selliah](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Selliah
No más puestos en curso
Historial de carrera de Robert Selliah
Antiguos cargos conocidos de Robert Selliah.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Ribapharm, Inc.
![]() Ribapharm, Inc. Pharmaceuticals: MajorHealth Technology Ribapharm, Inc. discovers, develops and markets antiviral and anticancer pharmaceuticals. The company is located in Costa Mesa, CA | Corporate Officer/Principal | - | - |
ARQULE, INC. | Corporate Officer/Principal | - | - |
Boehringer Ingelheim Pharmaceuticals, Inc.
![]() Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - | - |
Alcon Laboratories, Inc.
![]() Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Corporate Officer/Principal | - | - |
Prolexys Pharmaceuticals, Inc.
![]() Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. | Corporate Officer/Principal | - | - |
SAI Life Sciences Ltd.
![]() SAI Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology SAI Life Sciences Ltd. manufactures, develops, and discovers pharmaceutical drugs. The company was founded in 1999 and is headquartered in Hyderabad, India. | Corporate Officer/Principal | 29/12/2009 | - |
Formación de Robert Selliah.
The University of Texas at Austin | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
India | 2 |
Operativa
Corporate Officer/Principal | 6 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 7 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 6 |
---|---|
SAI Life Sciences Ltd.
![]() SAI Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology SAI Life Sciences Ltd. manufactures, develops, and discovers pharmaceutical drugs. The company was founded in 1999 and is headquartered in Hyderabad, India. | Health Technology |
Prolexys Pharmaceuticals, Inc.
![]() Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. | Health Technology |
Alcon Laboratories, Inc.
![]() Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
![]() Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
ArQule, Inc.
![]() ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
Ribapharm, Inc.
![]() Ribapharm, Inc. Pharmaceuticals: MajorHealth Technology Ribapharm, Inc. discovers, develops and markets antiviral and anticancer pharmaceuticals. The company is located in Costa Mesa, CA | Health Technology |
- Bolsa de valores
- Insiders
- Robert Selliah
- Experiencia